Kancera AB (Sweden) Market Value
KAN Stock | SEK 1.45 0.04 2.68% |
Symbol | Kancera |
Kancera AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kancera AB's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kancera AB.
04/22/2025 |
| 07/21/2025 |
If you would invest 0.00 in Kancera AB on April 22, 2025 and sell it all today you would earn a total of 0.00 from holding Kancera AB or generate 0.0% return on investment in Kancera AB over 90 days. Kancera AB is related to or competes with Combigene, Cantargia, Spectrumone Publ, and BioInvent International. Kancera AB , a biotechnology company, engages in the development and sale of drug candidates to pharmaceutical companies... More
Kancera AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kancera AB's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kancera AB upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 3.39 | |||
Information Ratio | 0.0581 | |||
Maximum Drawdown | 35.42 | |||
Value At Risk | (5.26) | |||
Potential Upside | 8.65 |
Kancera AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kancera AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kancera AB's standard deviation. In reality, there are many statistical measures that can use Kancera AB historical prices to predict the future Kancera AB's volatility.Risk Adjusted Performance | 0.0859 | |||
Jensen Alpha | 0.5738 | |||
Total Risk Alpha | (0.33) | |||
Sortino Ratio | 0.0969 | |||
Treynor Ratio | (0.52) |
Kancera AB Backtested Returns
Kancera AB appears to be extremely dangerous, given 3 months investment horizon. Kancera AB has Sharpe Ratio of 0.0612, which conveys that the firm had a 0.0612 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Kancera AB, which you can use to evaluate the volatility of the firm. Please exercise Kancera AB's Risk Adjusted Performance of 0.0859, mean deviation of 3.4, and Downside Deviation of 3.39 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Kancera AB holds a performance score of 4. The company secures a Beta (Market Risk) of -0.88, which conveys possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Kancera AB are expected to decrease slowly. On the other hand, during market turmoil, Kancera AB is expected to outperform it slightly. Please check Kancera AB's semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Kancera AB's current price movements will revert.
Auto-correlation | -0.28 |
Weak reverse predictability
Kancera AB has weak reverse predictability. Overlapping area represents the amount of predictability between Kancera AB time series from 22nd of April 2025 to 6th of June 2025 and 6th of June 2025 to 21st of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kancera AB price movement. The serial correlation of -0.28 indicates that nearly 28.0% of current Kancera AB price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.28 | |
Spearman Rank Test | 0.06 | |
Residual Average | 0.0 | |
Price Variance | 0.07 |
Kancera AB lagged returns against current returns
Autocorrelation, which is Kancera AB stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kancera AB's stock expected returns. We can calculate the autocorrelation of Kancera AB returns to help us make a trade decision. For example, suppose you find that Kancera AB has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Kancera AB regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kancera AB stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kancera AB stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kancera AB stock over time.
Current vs Lagged Prices |
Timeline |
Kancera AB Lagged Returns
When evaluating Kancera AB's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kancera AB stock have on its future price. Kancera AB autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kancera AB autocorrelation shows the relationship between Kancera AB stock current value and its past values and can show if there is a momentum factor associated with investing in Kancera AB.
Regressed Prices |
Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kancera Stock Analysis
When running Kancera AB's price analysis, check to measure Kancera AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kancera AB is operating at the current time. Most of Kancera AB's value examination focuses on studying past and present price action to predict the probability of Kancera AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kancera AB's price. Additionally, you may evaluate how the addition of Kancera AB to your portfolios can decrease your overall portfolio volatility.